Stock Splits
By The Online Investor Staff, updated Mon., Oct. 3, 1:47 PM
| This Slide: #9 of 25 |
Slide #9. First Wave BioPharma, Inc. (NASDAQ:FWBI) — 1 for 30 Reverse Split
Announced:
8/25/2022
Stock Split:
1 for 30
Record Date:
8/25/2022
Pay Date:
8/26/2022
FWBI Optionable?:
No
First Wave BioPharma engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Co. is focused on developing its drug product candidate, MS1819, a yeast derived recombinant lipase for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. Co.'s b-lactamase program focuses on products with an enzymatic combination of bacterial origin for the prevention of hospital-acquired infections and antibiotic-associated diarrhea by resistant bacterial strains induced by parenteral administration of several antibiotic classes. Co.'s compounds in pre-clinical development include: AZX1101 and AZX1103. 
FWBI Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the FWBI Page at The Online Investor (in a new window) »
 Free FWBI Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.00 out of 4) 21st percentile
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
